The child comes first
When interests could ever conflict, the wellbeing and dignity of the child is the overriding standard. Always, above all else.
An artificial womb touches the most profound questions a person can ask — about life, consent, personhood, and what it means to be a parent. The honest response is not to avoid them, but to lead with them. This is where we lay out what we believe, answer the questions we hear most, and open a door for yours — whether you are a parent, a clinician, an ethicist, or a member of the public with a concern.
Where we honestly stand. Amnia is at an early, pre-clinical stage. Nothing here is a claim of a finished product, an approval, or an active human trial. It is a statement of the principles we hold ourselves to and the questions we are working through in the open, so you can hold us to them. This is not medical advice.
These aren't marketing lines. They are the tests we apply to every decision — and any one of them can stop a project, regardless of how promising the science looks.
When interests could ever conflict, the wellbeing and dignity of the child is the overriding standard. Always, above all else.
Independent ethics and human-subjects oversight sits alongside the science with real authority to halt — not a sign-off collected at the end.
Parents decide. That consent must be offered honestly and without pressure, in what may be the hardest moment of their lives.
Every safety claim maps to a measurable, pre-specified endpoint reviewed by someone independent. If we can't measure it, we don't say it.
We publish our reasoning, our uncertainty, and our setbacks — not just our milestones. Trust is built in the open or not at all.
We draw a bright line between helping an already-born infant survive and full artificial gestation, and we don't cross it quietly.
It matters enormously which problem we are solving first. In the near term, Amnia is a bridge to viability for extremely premature infants — babies born so early that today's incubators and ventilators struggle to keep them alive. That is continuous with neonatal medicine, and the need is real today.
Full gestation from conception is a distant research horizon that raises far larger questions about personhood, viability, and reproduction. We keep the two separated — in our science, our language, and our public commitments — and we treat the second as a question for society, not a product decision for a company.
"The first question is never 'can we?' — it is 'should we, for this child, right now?'"
— Amnia ethics working group
No spin, no dodging. Where the honest answer is "we don't know yet," we say so. If your question isn't here, send it to us — the hard ones shape our work the most.
We don't claim to know yet — proving safety is the entire task ahead, not an assumption behind us. Amnia is pre-clinical. No child will ever enter an Amnia system until years of bench testing and large-animal survival studies, an FDA-authorised trial, and independent ethics and Data & Safety Monitoring Boards with the authority to stop have all cleared. If we cannot measure a safety claim, we do not make it. You can read the full evidence pathway on our regulatory roadmap.
In the near term, Amnia is a bridge for the most fragile premature infants — babies born so early that today's incubators struggle to keep them alive. The first people it is for are families facing loss in a NICU today. Full gestation from conception is a long-horizon research direction with far larger ethical questions, addressed openly and separately — not a near-term product.
A NICU treats a premature baby as a tiny newborn breathing air. Amnia keeps the physiology of the womb: the baby is immersed in sterile amniotic fluid and oxygenated through the umbilical cord via a synthetic placenta, so fragile lungs keep developing as they would before birth. We start here because the need is immediate, the comparison to current care is measurable, and the ethical framing — helping a child who is already born survive — is the clearest first step.
Parents are the decision-makers, and the consent they give must be genuinely informed — offered in an agonising, high-stakes moment, never rushed or oversold. Every study passes through an independent ethics committee (IRB) that can say no; informed-consent processes are designed with bioethicists; and the wellbeing of the child is the overriding standard whenever interests could conflict.
It is the central ethical question, and we do not blur it. Supporting an already-born premature infant is continuous with neonatal medicine. Gestating a human from conception entirely outside a body raises distinct questions about personhood, viability, and reproduction that society — not one company — must weigh in on. We keep the two clearly separated in our science, our language, and our public commitments.
No. Amnia exists to protect life that is at risk, not to replace the bond of pregnancy. For families who can carry safely, nothing changes. Our purpose is to give a chance to children for whom the current alternatives are failing.
We take dual-use and misuse seriously and discuss it openly rather than waiting to be asked. Clinical data is governed by strict research and privacy rules and reviewed by ethics boards. We commit to publishing our reasoning on hard questions, engaging critics directly, and declining directions we cannot pursue responsibly — even promising ones.
Medicine has always intervened to protect life that nature alone would lose — incubators, ventilators, and ECMO were each once called a step too far. We hold that view with humility: the goal is not to engineer life for its own sake, but to protect a specific, vulnerable child. That is why our principles put the child, consent, and independent oversight ahead of ambition.
The public and experts alike can reach the team directly here. We read every submission, we take critical ones seriously, and recurring questions get folded back into the FAQ above. Sharing your email is optional — give it only if you'd like a reply.